Siga Technologies INC

SIGA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $94.6M $138.7M $139.9M $110.8M $133.7M $125.0M $26.7M $477.1M
Cost of Revenue $29.7M $31.3M $17.8M $10.4M $16.6M $14.8M $1.8M $95.3M
Gross Profit $64.9M $107.4M $122.1M $100.3M $117.1M $110.2M $25.0M $381.8M
Gross Margin 68.6% 77.4% 87.3% 90.6% 87.6% 88.2% 93.3% 80.0%
Operating Expenses
Research & Development $20.0M $12.3M $16.4M $22.5M $9.9M $10.9M $13.3M $13.0M
SG&A Expense $21.2M $25.1M $22.0M $35.1M $18.0M $14.7M $13.3M $12.9M
Operating Income $23.7M $70.0M $83.6M $42.7M $89.1M $84.5M $-2.3M $355.1M
Operating Margin 25.1% 50.4% 59.8% 38.5% 66.7% 67.6% -8.7% 74.4%
Interest Expense $0 $0 $3.0M $15.8M $15.5M
Pretax Income $30.4M $76.1M $87.8M $44.1M $89.3M $73.5M $-10.2M $411.6M
Income Tax Expense $7.1M $16.9M $19.7M $10.2M $19.9M $17.2M $-2.9M $-10.2M
Net Income $23.3M $59.2M $68.1M $33.9M $69.5M $56.3M $-7.2M $421.8M
Net Margin 24.6% 42.7% 48.6% 30.6% 52.0% 45.1% -27.1% 88.4%
EPS (Basic) $0.33 $0.83 $0.95 $0.46 $0.92 $0.71 $-0.09 $5.28
EPS (Diluted) $0.32 $0.82 $0.95 $0.46 $0.91 $0.71 $-0.15 $5.18
Shares Outstanding (Basic) 71.5M 71.3M 71.4M 72.9M 75.3M 79.3M 81.0M 79.9M
Shares Outstanding (Diluted) 71.9M 71.9M 71.7M 73.5M 76.4M 79.4M 82.2M 82.7M
Dividends Per Share $0.60 $0.60 $0.45 $0.45
← Newer Page 1 of 2 Older →